ORASURE TECHNOLOGIES, INC

OSUR ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $77.0M
Cost of Revenue $29.9M
Gross Profit $47.1M
Gross Margin 61.2%
Operating Expenses
Research & Development $13.4M
SG&A Expense $16.8M
Operating Income $-8.8M
Operating Margin -11.4%
Interest Expense $361.2K
Pretax Income $-8.4M
Income Tax Expense $-622.3K
Net Income $-7.8M
Net Margin -10.1%
EPS (Basic) $-0.17
EPS (Diluted) $-0.17
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 3 of 3 Older →